Effects of semaglutide on clinical events in heart failure with preserved ejection fraction: a pooled, participant-level analysis of SELECT, FLOW, STEP-HFpEF and STEP-HFpEF DM trials

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Clinical trial updates on the GLP-1 receptor agonist, semaglutide Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by